{
    "2019-11-19": [
        [
            {
                "time": "2018-11-15",
                "original_text": "The Medicines Company Stock Is Soaring Because Novartis Might Want to Buy It",
                "features": {
                    "keywords": [
                        "Medicines Company",
                        "Novartis",
                        "buyout",
                        "soaring"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-15",
                "original_text": "Medicines Co. Is Said to Attract Suitors Including Novartis",
                "features": {
                    "keywords": [
                        "Medicines Co.",
                        "suitors",
                        "Novartis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-16",
                "original_text": "Merck's Heart Failure Candidate Meets Goal in Phase III Study",
                "features": {
                    "keywords": [
                        "Merck",
                        "heart failure",
                        "Phase III",
                        "candidate"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-16",
                "original_text": "Aerie to Acquire Dry Eye Disease-Focused Pharma Avizorex",
                "features": {
                    "keywords": [
                        "Aerie",
                        "acquire",
                        "Avizorex",
                        "dry eye disease"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-16",
                "original_text": "UPDATE 1-Novartis eyes Medicines Co to boost cardio franchise - report",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Medicines Co",
                        "cardio franchise"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-16",
                "original_text": "Why Vanguard’s chief economist says there is an elevated risk of a ‘large drawdown’ in stocks",
                "features": {
                    "keywords": [
                        "Vanguard",
                        "economist",
                        "drawdown",
                        "risk"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-16",
                "original_text": "Medicines Co. shares jump 17% in premarket after report of potential Novartis offer",
                "features": {
                    "keywords": [
                        "Medicines Co.",
                        "shares",
                        "jump",
                        "premarket",
                        "Novartis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-16",
                "original_text": "Novartis declines comment on reported interest in Medicines Co",
                "features": {
                    "keywords": [
                        "Novartis",
                        "declines",
                        "comment",
                        "Medicines Co."
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-16",
                "original_text": "[video]Medicines Co. Surges After Cholesterol Drug Maker Linked to Novartis Takeover",
                "features": {
                    "keywords": [
                        "Medicines Co.",
                        "surges",
                        "cholesterol drug",
                        "Novartis takeover"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-16",
                "original_text": "Home Depot, Kohl's, Boeing, Salesforce, Medicines Co. - 5 Things You Must Know",
                "features": {
                    "keywords": [
                        "Home Depot",
                        "Kohl's",
                        "Boeing",
                        "Salesforce",
                        "Medicines Co."
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "retail",
                        "aerospace",
                        "technology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-16",
                "original_text": "Medicines Co. Surges After Cholesterol Drug Maker Linked to Novartis Takeover",
                "features": {
                    "keywords": [
                        "Medicines Co.",
                        "surges",
                        "cholesterol drug",
                        "Novartis takeover"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}